Drugs / CT0591CP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05486975 | Aug 2022 → Jan 2025 | refractory plasma cell neoplasm | The First Affiliated Hospital of Soochow University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CT0591CP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05486975 ↗ |
| Modality | Cell therapy | “CT0591CP cells” NCT05486975 ↗ |